The use of ketamine to cope with depression and post-traumatic stress disorder: A qualitative analysis of the discourses posted on a popular online forum

References

• Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003 Jun 18;289:3095–105. doi:https://doi.org/10.1001/jama.289.23.3095.
   PubMed Web of Science ®Google Scholar
• Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B, Olesen J, Allgulander C, Alonso J, Faravelli C, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011 Sep;21:655–79. doi:https://doi.org/10.1016/j.euroneuro.2011.07.018.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the national comorbidity survey. Arch Gen Psychiatry. 1995;52:1048–60.doi:https://doi.org/10.1001/archpsyc.1995.03950240066012.
   PubMed Web of Science ®Google Scholar
• Burri A, Maercker A. Differences in prevalence rates of PTSD in various European countries explained by war exposure, other trauma and cultural value orientation. BMC Res Notes. 2014;7:407.doi:https://doi.org/10.1186/1756-0500-7-407.
   PubMedGoogle Scholar
• O’Donnell ML, Creamer M, Pattison P. Posttraumatic stress disorder and depression following trauma: understanding comorbidity. Am J Psychiatry. 2004;161:1390–96.doi:https://doi.org/10.1176/appi.ajp.161.8.1390.
   PubMed Web of Science ®Google Scholar
• Rytwinski NK, Scur MD, Feeny NC, Youngstrom EA. The co‐occurrence of major depressive disorder among individuals with posttraumatic stress disorder: a meta‐analysis. J Trauma Stress. 2013;26:299–309.doi:https://doi.org/10.1002/jts.21814.
   PubMed Web of Science ®Google Scholar
• Murrough JW. Ketamine as a novel antidepressant: from synapse to behavior. Clin Pharmacol Ther. 2012 Feb;91:303–09. doi:https://doi.org/10.1038/clpt.2011.244.
   PubMed Web of Science ®Google Scholar
• Ly C, Greb AC, Cameron LP, Wong JM, Barragan EV, Wilson PC, Burbach KF, Soltanzadeh Zarandi S, Sood A, Paddy MR, et al. Psychedelics promote structural and functional neural plasticity. Cell Rep. 2018;23:3170–82.
   PubMed Web of Science ®Google Scholar
• Mathew SJ, Zarate CA Jr. Ketamine for treatment-resistant depression: the first decade of progress. 1st ed. Switzerland: Springer International Publishing; 2016.
   Google Scholar
• Duman RS. 2018 May 24. Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide. F1000Res. 7:659. doi:https://doi.org/10.12688/f1000research.14344.1. Cited in PubMed; eCollection 2018.
   Google Scholar
• Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, Li X-Y, Aghajanian G, Duman RS. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science. 2010 Aug 20;329:959–64. doi:https://doi.org/10.1126/science.1190287.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Depression - fact sheet number 369; 2012. [accessed July 7th, 2014]. http://www.who.int/mediacentre/factsheets/fs369/en/.
   Google Scholar
• Albott CS, Lim KO, Forbes MK, Erbes C, Tye SJ, Grabowski JG, Thuras P, Batres-y-Carr TM, Wels J, Shiroma PR, et al. Efficacy, safety, and durability of repeated ketamine infusions for comorbid posttraumatic stress disorder and treatment-resistant depression. J Clin Psychiatry. 2018 May/Jun;79:3. doi:https://doi.org/10.4088/JCP.17m11634.
   Web of Science ®Google Scholar
• Feder A, Parides MK, Murrough JW, Perez AM, Morgan JE, Saxena S, Kirkwood K, Aan Het Rot M, Lapidus KAB, Wan L-B, et al. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2014;71:681–88.
   PubMed Web of Science ®Google Scholar
• Shalev AY, Freedman S, Peri T, Brandes D, Sahar T, Orr SP, Pitman RK. Prospective study of posttraumatic stress disorder and depression following trauma. Am J Psychiatry. 1998;155:630–37.
   PubMed Web of Science ®Google Scholar
• Caddy C, Giaroli G, White TP, Shergill SS, Tracy DK. Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy. Ther Adv Psychopharmacol. 2014 4;Apr: 75–99. doi:https://doi.org/10.1177/2045125313507739.
   Google Scholar
• DiazGranados N, Ibrahim LA, Brutsche NE, Ameli R, Henter ID, Luckenbaugh DA, et al. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. J Clin Psychiatry. 2010 Dec;71:1605–11. doi:https://doi.org/10.4088/JCP.09m05327blu.
   PubMed Web of Science ®Google Scholar
• Glue P, Gulati A, Le Nedelec M, Duffull S. Dose- and exposure-response to ketamine in depression. Biol Psychiatry. 2011 Aug 15;70:e9–10. author reply e11-2. doi:https://doi.org/10.1016/j.biopsych.2010.11.031.
   PubMed Web of Science ®Google Scholar
• Irwin SA, Iglewicz A. Oral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care. J Palliat Med. 2010 Jul;13:903–08. doi:https://doi.org/10.1089/jpm.2010.9808.
   PubMed Web of Science ®Google Scholar
• Lapidus KA, Levitch CF, Perez AM, Brallier JW, Parides MK, Soleimani L, Feder A, Iosifescu DV, Charney DS, Murrough JW, et al. A randomized controlled trial of intranasal ketamine in major depressive disorder. Biol Psychiatry. 2014 Dec 15;76:970–76. doi:https://doi.org/10.1016/j.biopsych.2014.03.026.
   PubMed Web of Science ®Google Scholar
• Lara DR, Bisol LW, Munari LR. Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression. Int J Neuropsychopharmacol. 2013 Oct;16:2111–17. doi:https://doi.org/10.1017/S1461145713000485.
   PubMed Web of Science ®Google Scholar
• Liebrenz M, Stohler R, Borgeat A. Repeated intravenous ketamine therapy in a patient with treatment-resistant major depression. World J Biol Psychiatry. 2009;10:640–43.doi:https://doi.org/10.1080/15622970701420481.
   PubMed Web of Science ®Google Scholar
• Stefanczyk-Sapieha L, Oneschuk D, Intravenous DM. ketamine “burst” for refractory depression in a patient with advanced cancer. J Palliat Med. 2008 Nov;11:1268–71.doi:https://doi.org/10.1089/jpm.2008.9828.
   PubMed Web of Science ®Google Scholar
• Thakurta RG, Das R, Bhattacharya AK, Saha D, Sen S, Singh OP, Bisui B. Rapid response with ketamine on suicidal cognition in resistant depression. Indian J Psychol Med. 2012 Apr;34:170–75. doi:https://doi.org/10.4103/0253-7176.101793.
   PubMedGoogle Scholar
• Salvadore G, Singh JB. Ketamine as a fast acting antidepressant: current knowledge and open questions. CNS Neurosci Ther. 2013 Jun;19:428–36. doi:https://doi.org/10.1111/cns.12103.
   PubMed Web of Science ®Google Scholar
• Diamond PR, Farmery AD, Atkinson S, Haldar J, Williams N, Cowen PJ, Geddes JR, McShane R. Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic. J Psychopharmacol. 2014 Apr 3;28:536–44. doi:https://doi.org/10.1177/0269881114527361.
   PubMed Web of Science ®Google Scholar
• Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000 Feb 15;47:351–54. doi:https://doi.org/10.1016/S0006-3223(99)00230-9.
   PubMed Web of Science ®Google Scholar
• Irwin SA, Iglewicz A, Nelesen RA, Lo JY, Carr CH, Romero SD, Lloyd LSDaily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: a 28-day open-label proof-of-concept trial. J Palliat Med. 2013 Aug;16:958–65. doi:https://doi.org/10.1089/jpm.2012.0617.
   PubMed Web of Science ®Google Scholar
• Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006 Aug;63:856–64. doi:https://doi.org/10.1001/archpsyc.63.8.856.
   PubMed Web of Science ®Google Scholar
• Zarate CA Jr, Brutsche NE, Ibrahim L, Franco-Chaves J, Diazgranados N, Cravchik A, Selter J, Marquardt CA, Liberty V, Luckenbaugh DA, et al. Replication of ketamine’s antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry. 2012 Jun 1;71:939–46. doi:https://doi.org/10.1016/j.biopsych.2011.12.010.
   PubMed Web of Science ®Google Scholar
• Paslakis G, Gilles M, Meyer-Lindenberg A, Deuschle M. Oral administration of the NMDA receptor antagonist S-ketamine as add-on therapy of depression: a case series. Pharmacopsychiatry. 2010 Jan;43:33–35. doi:https://doi.org/10.1055/s-0029-1237375.
   PubMed Web of Science ®Google Scholar
• Murrough JW, Perez AM, Pillemer S, Stern J, Parides MK, Aan Het Rot M, et al. Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry. 2013;74:250–56.
   PubMed Web of Science ®Google Scholar
• Liebrenz M, Borgeat A, Leisinger R, Stohler R. Intravenous ketamine therapy in a patient with a treatment-resistant major depression. Swiss Med Wkly. 2007 Apr 21;137:234–36. 2007/15/smw-11852.
   PubMed Web of Science ®Google Scholar
• Mathew SJ, Murrough JW, Aan Het Rot M, KA C, DL R, Charney DS. Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial. Int J Neuropsychopharmacol. 2010;13:71–82.
   PubMed Web of Science ®Google Scholar
• Price RB, Nock MK, Charney DS, Mathew SJ. Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biol Psychiatry. 2009 Sep 1;66:522–26. doi:https://doi.org/10.1016/j.biopsych.2009.04.029.
   PubMed Web of Science ®Google Scholar
• Lundin NB, Niciu MJ, Luckenbaugh DA, Ionescu DF, Richards EM, Vande Voort JL, Brutsche N, Machado-Vieira R, Zarate C. Baseline vitamin B12 and folate levels do not predict improvement in depression after a single infusion of ketamine. Pharmacopsychiatry. 2014 Jul;47:141–44. doi:https://doi.org/10.1055/s-0034-1377042.
   PubMed Web of Science ®Google Scholar
• Maeng S, Zarate CA Jr, Du J, Schloesser RJ, McCammon J, Chen G. Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry. 2008 Feb 15;63:349–52. doi:https://doi.org/10.1016/j.biopsych.2007.05.028.
   PubMed Web of Science ®Google Scholar
• Morgan CJ, Mofeez A, Brandner B, Bromley L, Curran HV. Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose–response study. Psychopharmacology (Berl). 2004;172:298–308.doi:https://doi.org/10.1007/s00213-003-1656-y.
   PubMed Web of Science ®Google Scholar
• Krupitsky EM, Burakov AM, Romanova TN, Grinenko NI, Grinenko AY, Fletcher J, Petrakis IL, Krystal JH. Attenuation of ketamine effects by nimodipine pretreatment in recovering ethanol dependent men: psychopharmacologic implications of the interaction of NMDA and L-type calcium channel antagonists. Neuropsychopharmacology. 2001;25:936–47.
   PubMed Web of Science ®Google Scholar
• Krystal JH, Petrakis IL, Webb E, Cooney NL, Karper LP, Namanworth S, Stetson P, Trevisan LA, Charney DS. Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics. Arch Gen Psychiatry. 1998;55:354–60.
   PubMed Web of Science ®Google Scholar
• Dakwar E, Nunes EV, Hart CL, Foltin RW, Mathew SJ, Carpenter KM. A single ketamine infusion combined with mindfulness-based behavioral modification to treat cocaine dependence: a randomized clinical trial. Am J Psychiatry. 2019;176:923–30.
   PubMed Web of Science ®Google Scholar
• Van Hout MC, Bingham T. ‘Surfing the Silk Road’: a study of users’ experiences. Int J Drug Policy. 2013 Nov;24:524–29. doi:https://doi.org/10.1016/j.drugpo.2013.08.011.
   PubMed Web of Science ®Google Scholar
• Davey Z, Schifano F, Corazza O, Deluca P. Psychonaut web mapping group. e-Psychonauts: conducting research in online drug forum communities. J Ment Health. 2012;21:386–94.
   PubMed Web of Science ®Google Scholar
• The Gallup Organization. Eurobarometer: youth attitudes on drugs - analytical report; 2011; [Accessed June 12, 2014]. http://ec.europa.eu/public_opinion/flash/fl_330_en.pdf.
   Google Scholar
• Deluca P, Davey Z, Corazza O, Di Furia L, Farre M, Flesland LH, Mannonen M, Majava A, Peltoniemi T, Pasinetti M, et al. Identifying emerging trends in recreational drug use; outcomes from the psychonaut web mapping project. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3;39:221–26. doi:https://doi.org/10.1016/j.pnpbp.2012.07.011.
   PubMed Web of Science ®Google Scholar
• Murguía E, Tackett-Gibson M. The new drugs internet survey: a portrait of respondents. In: Murguía E, Tackett-Gibson M, Lessem A, editors. Real drugs in a virtual world: drug discourse and community online. Plymouth: Lexington Books; 2007. p. 45–58.
   Google Scholar
• Tackett-Gibson M. Voluntary use, risk, and online drug use discourse. In: Murguía E, Tackett-Gibson M, Lessem A, editors. Real drugs in a virtual world: drug discourse and community online. Plymouth: Lexington Books; 2007. p. 67–82.
   Google Scholar
• Eysenbach G, Till JE. Ethical issues in qualitative research on internet communities. BMJ. 2001 Nov 10;323:1103–05. doi:https://doi.org/10.1136/bmj.323.7321.1103.
   PubMed Web of Science ®Google Scholar
• Rodham K, Gavin J. The ethics of using the internet to collect qualitative research data. Research Ethics Review. 2006 September 01;2:92–97. doi:https://doi.org/10.1177/174701610600200303.
   Google Scholar
• Bluelight. Bluelight research standards. [accessed March 28th, 2018]. http://www.bluelight.org/vb/content/76-Bluelight-Research-Standards.
   Google Scholar
• Melendez S In a world of opiate addicts, the internet plays doctor and therapist. [accessed January 18, 2014]. http://motherboard.vice.com/blog/in-a-world-of-opiate-addicts-the-internet-plays-doctor-and-therapist.
   Google Scholar
• Patton MQ. Qualitative research and evaluation methods. 3rd ed. Thousand Oaks, California: SAGE Publications; 2002.
   Google Scholar
• Bardin L. L’analyse de contenu. 1st ed. Vendôme, France: Presses Universitaires de France; 1977.
   Google Scholar
• Strauss A, Corbin J. Pesquisa qualitativa: técnicas e procedimentos para o desenvolvimento da teoria fundamentada. 2nd ed. Porto Alegre, Brazil: Artmed; 2008.
   Google Scholar
• Flick U. An introduction to qualitative research. 5th ed. London: SAGE Publications; 2014.
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Arlington, VA; Washington, D.C.: American Psychiatric Association; American Psychiatric Association; 2013.
   Google Scholar
• Bedard‐Gilligan M, Duax Jakob JM, Doane LS, Jaeger J, Eftekhari A, Feeny N, Zoellner LA. An investigation of depression, trauma history, and symptom severity in individuals enrolled in a treatment trial for chronic PTSD. J Clin Psychol. 2015;71:725–40.
   PubMed Web of Science ®Google Scholar
• Goforth HW, Holsinger T. Rapid relief of severe major depressive disorder by use of preoperative ketamine and electroconvulsive therapy. J Ect. 2007 Mar;23:23–25. doi:https://doi.org/10.1097/01.yct.0000263257.44539.23.
   PubMed Web of Science ®Google Scholar
• Duman RS, Aghajanian GK. Synaptic dysfunction in depression: potential therapeutic targets. Sci. 2012 Oct 5;338:68–72. doi:https://doi.org/10.1126/science.1222939.
   PubMed Web of Science ®Google Scholar
• Larkin GL, Beautrais AL. A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department. Int J Neuropsychopharmacol. 2011 Sep;14:1127–31. doi:https://doi.org/10.1017/S1461145711000629.
   PubMed Web of Science ®Google Scholar
• Russo SJ, Nestler EJ. The brain reward circuitry in mood disorders. Nat Rev Neurosci. 2013;14:609.doi:https://doi.org/10.1038/nrn3381.
   PubMed Web of Science ®Google Scholar
• Arnsten AF. Stress signalling pathways that impair prefrontal cortex structure and function. Nat Rev Neurosci. 2009;10:410.doi:https://doi.org/10.1038/nrn2648.
   PubMed Web of Science ®Google Scholar
• Kelly TM, Daley DC. Integrated treatment of substance use and psychiatric disorders. Soc Work Public Health. 2013;28:388–406.doi:https://doi.org/10.1080/19371918.2013.774673.
   PubMed Web of Science ®Google Scholar
• Reardon S. ‘Party drug’ turned antidepressant approaches approval. Nat Rev Drug Discov. 2018 Oct 30;17:773–75. doi:https://doi.org/10.1038/nrd.2018.187.
   PubMed Web of Science ®Google Scholar
• Huang PW, Meng E, Cha TL, Sun GH, Yu DS, Chang SY. ‘Walking-stick ureters’ in ketamine abuse. Kidney Int. 2011 Oct;80:895. doi:https://doi.org/10.1038/ki.2011.242.
   PubMed Web of Science ®Google Scholar
• Stichting Mainline. Mainline: drugs, gezondheid en de straat. Amsterdam: Stichting Mainline; 2017;26(3).
   Google Scholar
• Tackett-Gibson M. Constructions of risk and harm in online discussions of ketamine use. Addict Res Theory. 2008 January 1;16:245–57. doi:https://doi.org/10.1080/16066350801983699.
   Web of Science ®Google Scholar
• Salvadore G, Cornwell BR, Sambataro F, Latov D, Colon-Rosario V, Carver F, Holroyd T, DiazGranados N, Machado-Vieira R, Grillon C, et al. Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine. Neuropsychopharmacology. 2010 Jun;35:1415–22. doi:https://doi.org/10.1038/npp.2010.24.
   PubMed Web of Science ®Google Scholar
• Messer M, Haller IV, Larson P, Pattison-Crisostomo J, Gessert CE. The use of a series of ketamine infusions in two patients with treatment-resistant depression. J Neuropsychiatry Clin Neurosci. 2010 Fall;22:442–44. doi:https://doi.org/10.1176/jnp.2010.22.4.442.
   PubMed Web of Science ®Google Scholar
• Liu HT, Hollmann MW, Liu WH, Hoenemann CW, Durieux ME. Modulation of NMDA receptor function by ketamine and magnesium: Part I. Anesth Analg. 2001 May;92:1173–81. doi:https://doi.org/10.1097/00000539-200105000-00019.
   PubMed Web of Science ®Google Scholar
• Hollmann M, Boulter J, Maron C, Beasley L, Sullivan J, Pecht G, Heinemann S. Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor. Neuron. 1993 May;10:943–54. doi:https://doi.org/10.1016/0896-6273(93)90209-A.
   PubMed Web of Science ®Google Scholar
• Rassendren FA, Lory P, Pin JP, Nargeot J. Zinc has opposite effects on NMDA and non-NMDA receptors expressed in Xenopus oocytes. Neuron. 1990 May;4:733–40. doi:https://doi.org/10.1016/0896-6273(90)90199-P.
   PubMed Web of Science ®Google Scholar
• Ibrahim L, Diazgranados N, Franco-Chaves J, Brutsche N, Henter ID, Kronstein P, Moaddel R, Wainer I, Luckenbaugh DA, Manji HK, et al. Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study. Neuropsychopharmacology. 2012 May;37:1526–33. doi:https://doi.org/10.1038/npp.2011.338.
   PubMed Web of Science ®Google Scholar
• Yasmin S, Carpenter LL, Leon Z, Siniscalchi JM, Price LH. Adjunctive gabapentin in treatment-resistant depression: a retrospective chart review. J Affect Disord. 2001 Mar;63:243–47. doi:https://doi.org/10.1016/S0165-0327(00)00187-7.
   PubMed Web of Science ®Google Scholar
• Wikipedia. Ergoloid; 2014. [Accessed June 13th]. http://en.wikipedia.org/wiki/Ergoloid.
   Google Scholar
• Sachs GS, Gelenberg AJ, Bellinghausen B, Wojcik J, Falk WE, Farhadi AM, Jenike M. Ergoloid mesylates and ECT. J Clin Psychiatry. 1989 Mar;50:87–90.
   PubMed Web of Science ®Google Scholar
• Corazza O, Schifano F, Simonato P, Fergus S, Assi S, Stair J, Corkery J, Trincas G, Deluca P, Davey Z, et al. Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine. Hum Psychopharmacol. 2012 Mar;27:145–49. doi:https://doi.org/10.1002/hup.1242.
   PubMed Web of Science ®Google Scholar
• Halpern JH, Pope HG Jr. Hallucinogens on the Internet: a vast new source of underground drug information. Am J Psychiatry. 2001 Mar;158:481–83. doi:https://doi.org/10.1176/appi.ajp.158.3.481.
   PubMed Web of Science ®Google Scholar
• Carhart-Harris RL, LA K, Nutt DJ. A web-based survey on mephedrone. Drug Alcohol Depend. 2011 Oct 1;118:19–22. doi:https://doi.org/10.1016/j.drugalcdep.2011.02.011.
   PubMed Web of Science ®Google Scholar
• Schifano F, Deluca P, Agosti L, Martinotti G, Corkery JM, Alex B, et al. New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 (‘Blue Mystic’). J Psychopharmacol. 2005 Nov;19:675–79. doi:https://doi.org/10.1177/0269881105056660.
   PubMed Web of Science ®Google Scholar
• Minayo MCS. O desafio do conhecimento: pesquisa qualitativa em saúde. 8th ed. Sao Paulo: Hucitec; 2004.
   Google Scholar